> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Determines 10 ANDAs Not Withdrawn for S&E
- URL: https://www.fdaweb.com/fda-determines-10-andas-not-withdrawn-for-s-e/
- Published: 2016-04-04T12:00:00.000Z
- Updated: 2026-09-14T20:52:40.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5135262

*Federal Register* Notice: FDA has determined that the drug products listed in this document were not withdrawn from sale for reasons of safety or effectiveness. This determination means that the agency will not begin procedures to withdraw approval of ANDAs that refer to these drug products, and it will allow it to continue to approve ANDAs that refer to the products as long as they meet relevant legal and regulatory requirements. These products are Pronestyl, Symmetrel, Ovcon-35, Topicort LP, Campral, Oxacilllin Sodium, Bactocill, Thiotepa, Sulfamethoxazole, and Trimethoprim. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-04-04/pdf/2016-07610.pdf?ref=fdaweb.com)